EI

266.6

+0.91%↑

SAN

79.56

-1.34%↓

MRK1

107

+0.23%↑

SHL.DE

47.85

+0.29%↑

ARGX

637.8

-1.24%↓

EI

266.6

+0.91%↑

SAN

79.56

-1.34%↓

MRK1

107

+0.23%↑

SHL.DE

47.85

+0.29%↑

ARGX

637.8

-1.24%↓

EI

266.6

+0.91%↑

SAN

79.56

-1.34%↓

MRK1

107

+0.23%↑

SHL.DE

47.85

+0.29%↑

ARGX

637.8

-1.24%↓

EI

266.6

+0.91%↑

SAN

79.56

-1.34%↓

MRK1

107

+0.23%↑

SHL.DE

47.85

+0.29%↑

ARGX

637.8

-1.24%↓

EI

266.6

+0.91%↑

SAN

79.56

-1.34%↓

MRK1

107

+0.23%↑

SHL.DE

47.85

+0.29%↑

ARGX

637.8

-1.24%↓

Search

Fagron

Uždarymo kaina

SektoriusSveikatos priežiūra

19.96 -3.57

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

19.9

Max

20.8

Pagrindiniai rodikliai

By Trading Economics

Pajamos

40M

Pardavimai

443M

P/E

Sektoriaus vid.

17.992

35.664

Pelnas, tenkantis vienai akcijai

0.55

Dividendų pajamingumas

1.66

Pelno marža

9.066

Darbuotojai

3,989

EBITDA

71M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+20.59% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.66%

3.12%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

1.5B

Ankstesnė atidarymo kaina

23.53

Ankstesnė uždarymo kaina

19.96

Naujienos nuotaikos

By Acuity

50%

50%

148 / 371 reitingas Healthcare

Fagron Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-09-12 22:41; UTC

Pagrindinės rinkos jėgos

GlucoTrack Stock Falls on Plans to Sell $3 Million Note

2025-09-12 16:04; UTC

Pagrindinės rinkos jėgos

Upexi Shares Climb on Solana Gains

2025-09-14 23:48; UTC

Rinkos pokalbiai

Oil Futures Mixed Amid Divergent Signals -- Market Talk

2025-09-14 23:41; UTC

Rinkos pokalbiai

Gold Edges Lower on Likely Technical Correction -- Market Talk

2025-09-14 23:38; UTC

Rinkos pokalbiai

China's Economic Activity Data May Continue Reflecting Slowdown -- Market Talk

2025-09-14 23:13; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-09-14 23:13; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2025-09-14 23:13; UTC

Rinkos pokalbiai

Infratil May Need to Be More Aggressive With Asset Sales -- Market Talk

2025-09-14 23:13; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-09-14 23:04; UTC

Rinkos pokalbiai

Aristocrat's Interactive Unit Appears in Safe Hands -- Market Talk

2025-09-13 08:20; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-09-12 20:50; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-09-12 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-09-12 20:09; UTC

Uždarbis

Correction to Opendoor Is Sliding. Don't Call It a Meme Stock, Says New Chairman. -- Barrons.com

2025-09-12 19:23; UTC

Rinkos pokalbiai

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

2025-09-12 19:16; UTC

Rinkos pokalbiai

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

2025-09-12 19:03; UTC

Rinkos pokalbiai

Natural Gas Futures Held Back By Plump Inventories -- Market Talk

2025-09-12 18:59; UTC

Rinkos pokalbiai

Dollar Pares Gains as Economy Keeps Showing Signs of Cooling -- Market Talk

2025-09-12 18:38; UTC

Rinkos pokalbiai
Uždarbis

Adobe Seen Reaching Turning Point in AI Cycle -- Market Talk

2025-09-12 18:33; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Rises By 2 to 416 -- Market Talk

2025-09-12 18:22; UTC

Rinkos pokalbiai

Canada's Divergence With US On Capex Spending is 'Appalling' -- Market Talk

2025-09-12 16:56; UTC

Rinkos pokalbiai

Renewable Fuels Association Calls for Nationwide E15 Following WASDE -- Market Talk

2025-09-12 16:22; UTC

Uždarbis

Adobe Earnings Were 'Solid.' Long-Term Growth Concerns Remain. -- Barrons.com

2025-09-12 16:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-09-12 16:19; UTC

Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

2025-09-12 16:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-09-12 16:11; UTC

Uždarbis

Novartis Catches a 'Sell.' Goldman Sachs Says the Stock Is Overvalued. -- Barrons.com

2025-09-12 15:37; UTC

Rinkos pokalbiai

Gold Holds Near All-Time Highs Ahead of Fed Meeting Next Week -- Market Talk

2025-09-12 15:22; UTC

Rinkos pokalbiai

European Gas Lifted by Geopolitical Risks But Storage Levels Ease Supply Fears -- Market Talk

2025-09-12 15:07; UTC

Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Fagron Prognozė

Kainos tikslas

By TipRanks

20.59% į viršų

12 mėnesių prognozė

Vidutinis 19.5 EUR  20.59%

Aukščiausias 19.5 EUR

Žemiausias 19.5 EUR

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Fagron kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

1

Pirkti

0

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

148 / 371 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Fagron

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
help-icon Live chat